43 ingredients subject to bioequivalence test in 2004

The Korea Food and Drug Administration (KFDA) said the bioequivalence tests of 43 ingredients with narrow therapeutic thresfolds will take effect on 43 from July 1, 2004 on a mandatory basis.

Ingredients to be included in the mandatory list of bioequivlance tests are aplindine, carbamazepine, clindamycin, clonazepam, clonidine, cyclosporin, digitoxin, digoxin, disopiramide, ethinylestradiol...